Univercells tie-up for affordable personalised cancer care

Serum Institute, Univercells tie-up for affordable personalised cancer care Serum Institute of India (SII) is collaborating with Univercells to bring affordable personalised oncology to the masses. Univercells is a Belgian biotech company working on increasing accessibility to personalised cancer care. This partnership aims to bring cutting-edge treatment options within reach of millions globally, Univercells said. “At present, personalised care options such as novel cancer vaccines and specialised immunotherapies are accessible to a few patients only. These new therapies, developed using genetic material extracted from the patient’s tumors, are time-consuming and expensive.Besides, due to strict regulatory limitations on the sequence, transfer, and manufacturing of genetic material, these treatments are only available in a handful of countries,” the company said. [Read more]( If you would prefer not receiving our emails, please [Click Here](